Duchembio Co., Ltd. specializes in advanced biotechnological solutions, focusing on the development of innovative products for various applications in the life sciences sector. The company employs cutting-edge techniques in synthetic biology and molecular engineering to create high-performance bioproducts. Their pipeline includes a range of biopharmaceuticals and diagnostic tools designed to enhance healthcare outcomes and streamline research processes. By leveraging their expertise in genetic manipulation and protein engineering, Duchembio aims to address critical challenges in drug development and disease management.

In addition to their product offerings, Duchembio is committed to scientific research and development, utilizing state-of-the-art technologies to drive innovation. Their research initiatives encompass areas such as genomics, proteomics, and bioinformatics, enabling them to explore new therapeutic avenues and improve existing solutions. The company emphasizes collaboration with academic institutions and industry partners to foster knowledge exchange and accelerate the translation of scientific discoveries into practical applications. Through these efforts, Duchembio Co., Ltd. positions itself as a leader in the biotechnology field, dedicated to advancing health and wellness through science and technology.

South Korea

Developing new radiopharmaceuticals for cancer diagnosis & treatment, and achieving successful commercialization locally & globally

Duchembio Co., Ltd.

Company Details